AMNIVUZ Trademark

Trademark Overview

On Tuesday, April 29, 2025, a trademark application was filed for AMNIVUZ with the United States Patent and Trademark Office. The USPTO has given the AMNIVUZ trademark a serial number of 99161396. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, June 24, 2025. This trademark is owned by Amgen Inc.. The AMNIVUZ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders; pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke
amnivuz

General Information

Serial Number99161396
Word MarkAMNIVUZ
Filing DateTuesday, April 29, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, June 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders; pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 29, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Trademark Events

Event DateEvent Description
Tuesday, April 29, 2025NEW APPLICATION ENTERED
Tuesday, April 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 23, 2025ASSIGNED TO EXAMINER
Tuesday, June 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 29, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, June 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 25, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, June 25, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, June 24, 2025NON-FINAL ACTION E-MAILED

Related Keywords

amnivuz preparations pharmaceutical treatment disorders diseases system obesity breathing asthma other